Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy

Published:2014-04-06 Issue:1 Volume:145 Page:245-254
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Hertz Daniel L.,Roy Siddharth,Jack John,Motsinger-Reif Alison A.,Drobish Amy,Clark L. Scott,Carey Lisa A.,Dees E. Claire,McLeod Howard L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2910-1.pdf

Reference49 articles.

1. Diéras V, Fumoleau P, Romieu G, Tubiana-Hulin M, Namer M, Mauriac L et al (2004) Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer. J Clin Oncol 22(24):4958–4965

2. Martin M, Rodriguez-Lescure Ã, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M et al (2008) Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. J Natl Cancer Inst 100(11):805–814

3. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S et al (2003) Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21(6):976–983

4. Freilich RJ, Balmaceda C, Seidman AD, Rubin M, DeAngelis LM (1996) Motor neuropathy due to docetaxel and paclitaxel. Neurology. 47(1):115–118

5. Mielke S, Mross K, Gerds TA, Schmidt A, Wasch R, Berger DP et al (2003) Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h. Anticancer Drugs 14(10):785–792

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An up-to-date view of paclitaxel-induced peripheral neuropathy;Journal of Cancer Research and Therapeutics;2023-12

2. Omics Technologies Improving Breast Cancer Research and Diagnostics;International Journal of Molecular Sciences;2023-08-11

3. Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review;Frontiers in Pain Research;2023-05-12

4. VALIDATION OF A SIMPLE GENOTYPING PANEL ASSAY FOR PHARMACOGENOMICS OF TAXANE-BASED THERAPY: PRELIMINARY RESULTS;WORLD CANCER RES J;2023

5. Breast cancer pharmacogenetics: a systematic review;Pharmacogenomics;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3